These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1863268)

  • 1. Diadenosine polyphosphates inhibit the action of ribonucleotide reductase on ADP.
    Wasternack C; Günther Sillero MA; Sillero A
    Biochem Int; 1991 Jan; 23(1):151-6. PubMed ID: 1863268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
    Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
    J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of diadenosine polyphosphates in human tears.
    Pintor J; Carracedo G; Alonso MC; Bautista A; Peral A
    Pflugers Arch; 2002 Jan; 443(3):432-6. PubMed ID: 11810214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity.
    Yegutkin GG; Jankowski J; Jalkanen S; Günthner T; Zidek W; Jankowski V
    Biosci Rep; 2008 Aug; 28(4):189-94. PubMed ID: 18576946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
    Kucera R; Brown CL; Paulus H
    J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the cytidine 5'-diphosphate and adenosine 5'-diphosphate reductase activities of mammalian ribonucleotide reductase.
    Cory JG; Mansell MM
    Cancer Res; 1975 Sep; 35(9):2327-31. PubMed ID: 167952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reduction in intact human diploid fibroblasts.
    Dick JE; Wright JA
    J Cell Physiol; 1980 Oct; 105(1):63-72. PubMed ID: 7000802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinucleotide analogues as inhibitors of thymidine kinase, thymidylate kinase, and ribonucleotide reductase.
    Davies LC; Stock JA; Barrie SE; Orr RM; Harrap KR
    J Med Chem; 1988 Jul; 31(7):1305-8. PubMed ID: 2838631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
    Cory JG; Fleischer AE
    Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantification of diadenosine polyphosphate concentrations in human plasma.
    Jankowski J; Jankowski V; Laufer U; van der Giet M; Henning L; Tepel M; Zidek W; Schlüter H
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1231-8. PubMed ID: 12738682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets.
    Jankowski J; Potthoff W; van der Giet M; Tepel M; Zidek W; Schlüter H
    Anal Biochem; 1999 Apr; 269(1):72-8. PubMed ID: 10094777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
    McClarty GA; Chan AK; Wright JA
    Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
    Cory JG; Fleischer AE
    Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of ribonucleotide reductase catalytic oxidation establishes thioredoxins as its major reductants in yeast.
    Camier S; Ma E; Leroy C; Pruvost A; Toledano M; Marsolier-Kergoat MC
    Free Radic Biol Med; 2007 Apr; 42(7):1008-16. PubMed ID: 17349928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd).
    Zahedi Avval F; Berndt C; Pramanik A; Holmgren A
    Biochem Biophys Res Commun; 2009 Feb; 379(3):775-9. PubMed ID: 19121624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquid chromatography.
    Decosterd LA; Cottin E; Chen X; Lejeune F; Mirimanoff RO; Biollaz J; Coucke PA
    Anal Biochem; 1999 May; 270(1):59-68. PubMed ID: 10328765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates.
    Stavrou BM; Sheridan DJ; Flores NA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):531-8. PubMed ID: 11454914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.